- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01451983
Genetics, Brain Structure and Thinking Skills in Autism
7. januar 2015 opdateret af: Thomas W. Frazier, Ph.D, The Cleveland Clinic
Genetic, Biochemical, Behavioral and Neuroimaging Phenotypes of Autism Spectrum Disorders (ASDs)
The purpose of this research is to better understand the genetic, biochemical, cognitive and behavioral symptom abnormalities that contribute to autism spectrum disorders.
The investigators anticipate recruiting at least 100 participants with autism spectrum disorder and large head size, at least 100 participants with autism spectrum disorder without large head size and at least 40 healthy siblings.
Biological parents are expected to be recruited only as genetic changes are identified in individuals with autism spectrum disorders to better understand the nature of these genetic changes.
Participants are asked to complete cognitive testing, a blood draw, urine collection and measurement of his/her height, weight and head circumference.
Parents or caregivers may be asked to complete a diagnostic evaluation and will complete questionnaires that examine the participant's medical and family history as well as his/her current symptoms, functioning, and quality of life.
A brief report simply listing and giving a basic description of any behavioral diagnostic information, autism symptoms, adaptive functioning, and a listing of results from cognitive testing will be provided as part of this study.
Studieoversigt
Status
Afsluttet
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
138
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44104
- Cleveland Clinic Center for Autism
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
2 år til 50 år (Barn, Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
We anticipate recruiting 80 participants with autism spectrum disorder and large head size, 80 participants with autism spectrum disorder without large head size and 40 healthy siblings.
Biological parents are expected to be recruited only as genetic changes are identified in individuals with autism spectrum disorders to better understand the nature of these genetic changes.
Beskrivelse
Inclusion Criteria:
- Clinical diagnosis of autism
- Consent from parents or guardians or an adult with or suspected of having an autism spectrum disorder that does not require a legal guardian or an adult who is the healthy sibling of an individual with an autism spectrum disorder.
- Youth ages 2-17 and adults ages 18-50. Youths and adults who are able (some young or severely impaired participants may not be able to provide assent) will be asked to provide assent.
- Families with multiple children who meet the above inclusion criteria will be permitted to have as many children participate as they wish.
- Youth ages 2-17 and adults ages 18-50 who do not have an autism spectrum disorder or are not suspected of having an autism spectrum disorder and who have a sibling with an autism spectrum disorder who has participated in the present study.
Exclusion Criteria:
- Clinically significant medical disease that would prohibit participation in the study procedures.
- Children younger than 2 years old and adults older than 50 years old.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
ASD with PTEN
Individuals with autism spectrum disorder who are also found to have a PTEN mutation.
|
|
ASD no PTEN macrocephaly
Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.
|
|
ASD no PTEN no macrocephaly
Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.
|
|
Siblings
Siblings of individuals with autism spectrum disorders.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Total Brain Volume
Tidsramme: Baseline
|
Baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Thomas W Frazier, Ph.D., The Cleveland Clinic
- Ledende efterforsker: Charis Eng, M.D., Ph.D., The Cleveland Clinic
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. maj 2010
Primær færdiggørelse (Faktiske)
1. august 2014
Studieafslutning (Faktiske)
1. august 2014
Datoer for studieregistrering
Først indsendt
11. oktober 2011
Først indsendt, der opfyldte QC-kriterier
13. oktober 2011
Først opslået (Skøn)
14. oktober 2011
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
14. januar 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. januar 2015
Sidst verificeret
1. januar 2015
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CCF 09-624
- UL1RR024989 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Autismespektrumforstyrrelser
-
Sohag UniversityTilmelding efter invitationPlacenta Accrete SpectrumEgypten
-
Charite University, Berlin, GermanyRekrutteringSkizofreni Spectrum Disorders (SSD)Tyskland
-
Corestemchemon, Inc.Ikke rekrutterer endnuNeuromyelitis Optica Spectrum Disorder Tilbagefald
-
Kasr El Aini HospitalRekrutteringGraviditet | Apgar score | Tourniquets | Placenta Accrete SpectrumEgypten
-
Assiut UniversityUkendtPlacenta Accrete SpectrumEgypten
-
Novartis PharmaceuticalsAfsluttetPIK3CA-Relateret Overgrowth Spectrum (PROS)Spanien, Frankrig, Australien, Forenede Stater, Irland
-
Jagannadha R AvasaralaAfsluttetMultipel sclerose | Optisk neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Neuromyelitis Optica Spectrum Disorder Tilbagefald | Neuromyelitis Optica Spectrum Disorder ProgressionForenede Stater
-
University of Trás-os-Montes and Alto DouroCentro Hospitalar De Trás-Os-Montes E Alto Douro, E.P.E.RekrutteringPsykotiske lidelser | Svær psykisk sygdom | Skizofreni Spectrum Disorders (SSD)Portugal
-
Feng JinzhouIkke rekrutterer endnuNeuromyelitis Optica Spectrum Disorders
-
BiocadAktiv, ikke rekrutterendeNeuromyelitis Optica Spectrum DisordersDen Russiske Føderation